English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Rationale: Platelet activation after contact to subendothelial collagen leads to acute arterial thrombosis. ANXA7 (Annexin A7) is a phospholipid-binding protein participating in the regulation of intracellular Ca2+ and exocytosis.Objective: The present study aimed to determine the role of ANXA7 in platelet Ca2+ signaling and lipid metabolism during platelet activation in arterial thrombosis using the ANXA7 inhibitor 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) and gene-targeted mice lackingAnxa7 (Anxa7 −/− ).Methods and Results: ANXA7 is strongly expressed in platelets. Functionally, luminescence aggregometry revealed significantly abrogated aggregation and secretion of ABO-treated orAnxa7 −/− platelets when compared with untreated orAnxa7 +/+ platelets after activation with collagen or the GPVI (glycoprotein VI)-specific agonist collagen-related peptide. Furthermore, while both thrombus formation on collagen-coated surfaces under high arterial shear rates in ABO-treated orAnxa7 -deficient whole blood, and thrombotic vascular occlusion after FeCl3 -induced injury in vivo inAnxa7 −/− bone marrow chimeric mice were significantly diminished, no prolongation of bleeding time was observed in ABO-treated orAnxa7 −/− mice. Fura-2-AM spectrofluorimetry unraveled a blunted [Ca2+ ]i increase in ABO-treated orAnxa7 −/− platelets after GPVI stimulation. Due to an abolished phospholipase Cγ2 phosphorylation,Anxa7 −/− platelets displayed abrogated intracellular Ca2+ mobilization following collagen-related peptide-dependent platelet activation. Quantitative lipidomics analysis further revealed that ANXA7 critically affects platelet oxylipin metabolism following GPVI-dependent platelet activation.Anxa7 −/− platelets showed a significantly reduced generation of several bioactive metabolites, particularly thromboxane A2 and 12(S)-hydroxy-eicosatetraenoic acid. Finally, defective phospholipase Cγ2 phosphorylation and blunted [Ca2+ ]i increase inAnxa7 −/− platelets could be rescued by exogenous addition of 12(S)-hydroxy-eicosatetraenoic acid, indicating that ANXA7 is a critical regulator of the platelet 12-lipoxygenase in GPVI-dependent platelet Ca2+ signaling during arterial thrombosis.Conclusions: The present study unravels ANXA7 as a regulator of oxylipin metabolism and Ca2+ -dependent platelet activation downstream of GPVI. ANXA7 plays an important role in platelet signaling during arterial thrombosis and thus may reflect a promising target for novel antiplatelet strategies.

ANXA7 Regulates Platelet Lipid Metabolism and Ca 2+ Release in Arterial Thrombosis

ANXA7 Regulates Platelet Lipid Metabolism and Ca ²⁺ Release in Arterial Thrombosis